Latest

Time to sell again?

Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits - writing exclusively for Master Investor.

There are no safe havens

Ranjeet Singh discusses the signs that the current sell-off could be the start of something a lot bigger - and…

Whitbread results put off investors despite sale approval

FTSE 250 hospitality firm Whitbread saw first half revenues grow by 2.6% as the number of rooms in its UK…

Plus500 grows despite rough third quarter

Plus500 has said that trading for 2018 will be ahead of current expectations despite revenues for the third quarter being…

Camellia sees positive results in tea leaves

AIM-listed Camellia has said that volumes at its agricultural operations will be at or near record highs with good prices for…

SalvaRx boosted by drug results

Shares in AIM-listed SalvaRX rose by 8.55% to 73p after a clinical biotechnology firm in which it has an 8% holding…

NetScientific secures Series A funding for portfolio firm

Healthcare IP commercialisation specialist NetScientific has announced a successful series A fundraising for Glycotest with Chinese healthcare group.

Equiniti hits recovery milestone

FTSE 250 fintech business Equiniti has said that its asset reunification business ProSearch has reconnected £1 billion in unclaimed assets…

Evil Knievil: This will be an interesting trial or two

Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits - writing exclusively for Master Investor.

Investors check out of InterContinental Hotels despite cash return

Hospitality group InterContinental Hotels Group reported that it would return $500 million to shareholders via a special dividend and share…